Correlation Between Immune-Related Adverse Events and Prognosis in Hepatocellular Carcinoma Patients Treated With Immune Checkpoint Inhibitors

BACKGROUND: Immune-related adverse events (irAEs) caused by immune checkpoint inhibitors (ICIs) were associated with clinical benefit in cancer patients of melanoma, a lung cancer. In the present study, we investigated the correlation between irAE and ICI efficacy in hepatocellular carcinoma (HCC) p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Shuo, Lai, Ruixue, Zhao, Qian, Zhao, Pandong, Zhao, Ruili, Guo, Zhanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691363/
https://www.ncbi.nlm.nih.gov/pubmed/34950153
http://dx.doi.org/10.3389/fimmu.2021.794099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691363/
https://www.ncbi.nlm.nih.gov/pubmed/34950153
http://dx.doi.org/10.3389/fimmu.2021.794099

Ejemplares similares